Fisher & Paykel Healthcare Corporation Limited

FPH.NZ · NZE

Market closed39.930.280000 (+0.71%)

Key statistics

Previous close39.65

Open39.20

Day high40.10

Day low39.03

52-week high41.40

52-week low32.16

Market cap23.45B

Volume293.30K

Average volume525.45K

P/E ratio51.35

Forward P/E—

EPS0.78

Dividend yield+1.53%

Market context

Why it moved

Fisher & Paykel Healthcare (FPH.NZ) edged higher amid broadly positive market sentiment in the New Zealand and broader Asia-Pacific healthcare sector, with investor attention also turning to the company's upcoming earnings calendar appearance.

Facebook Stocktitan Instagram Brainhunter Facebook

What is happening

Recent company-specific developments and publisher coverage.

Mt Newswire · May 26, 2026Fisher & Paykel Healthcare's Fiscal 2026 Results in Line with Forecasts for Revenue, 2% above Net Profit after Tax, Jefferies Says

Mt Newswire · May 26, 2026Update: Fisher & Paykel Healthcare Posts Higher Fiscal 2026 Underlying Earnings, Revenue; Shares Up 7%

Mt Newswire · May 25, 2026Fisher & Paykel Healthcare Posts Higher Fiscal 2026 Underlying Earnings, Revenue

Mt Newswire · May 21, 2026Fisher & Paykel Navigates Increased Geopolitical Volatility while Managing Business for Long-Term, Jefferies Says

Mt Newswire · February 23, 2026New Zealand Shares End Higher Amid Trump's Reaction to Supreme Court Tariff Ruling; Chorus Swings to Fiscal H1 Profit as Revenue Rises

Mt Newswire · February 23, 2026Fisher & Paykel Healthcare Upgrades Fiscal 2026 Revenue, NPAT Guidance; Shares Up 5%

Mt Newswire · January 7, 2026Fisher & Paykel Healthcare Says AustralianSuper Raises Stake

Mt Newswire · December 12, 2025NZX Midday Sector Update: Consumer Durables Soar, Health Technology Struggles

Peers

ResMed Inc.RMD · $198.99-1.86%

Medtronic plcMDT · $83.20-0.43%

Becton, Dickinson and CompanyBDX · $158.17-1.10%

Koninklijke Philips N.V.PHG · $26.95-1.25%

Nanosonics LimitedNAN.AX · 3.15-3.67%

Intuitive Surgical, Inc.ISRG · $345.42-14.15%

Alcon Inc.ALC · $70.26-0.51%

The Cooper Companies, Inc.COO · $71.71-1.90%

West Pharmaceutical Services, Inc.WST · $358.48-1.09%

Coloplast A/SCOLO-B.CO · 422.80+2.13%

Align Technology, Inc.ALGN · $176.76-0.92%

Solventum CorporationSOLV · $81.31-0.48%

Company profile

Fisher & Paykel Healthcare Corporation Limited (NZE: FPH) is a leading New Zealand-based global designer, manufacturer, and marketer of medical device products and systems for use in acute and chronic respiratory care, surgery, and the treatment of obstructive sleep apnea (OSA), with its products sold in over 120 countries worldwide. Founded in 1934 and headquartered in Auckland, New Zealand, the company operates across two primary segments — Hospital and Homecare — offering a comprehensive portfolio that includes humidification systems, nasal high flow therapy devices, invasive and noninvasive ventilation solutions, CPAP masks, flow generators, and data management technologies. Recognised as one of the three largest respiratory care device companies globally, Fisher & Paykel Healthcare holds a market-leading position in hospital humidifiers and related consumables, and ranks as the third-largest player in the home-based treatment of sleep apnea. With manufacturing facilities in New Zealand and Mexico, approximately 7,500 employees worldwide, and a market capitalisation of approximately NZ$22.6 billion, the company generates around 42% of its revenue from the United States, 32% from Europe, and 18% from the Asia-Pacific region.

Symbol: FPH.NZ
Exchange: NZE
Sector: Healthcare
Industry: Medical - Instruments & Supplies
CEO: Lewis G. Gradon
Employees: 6,978
Country: NZ
IPO date: 2000-01-01
Website: fphcare.com

Analyst consensus

hold

0 ratings

Low0.00Average0.00High0.00